News/SEC filing/Apr 22, 2026, 4:03 PM ET

Amgen files 8-K: Director/Officer Change

AmgenAMGN

Amgen filed a Form 8-K with the SEC on Apr 22, 2026, 4:03 PM ET, reporting an event dated Apr 22, 2026. It covers Item 5.02 (Departure or Election of Directors or Officers; Compensatory Arrangements); Item 9.01 (Financial Statements and Exhibits).

  • Form 8-K accepted by EDGAR Apr 22, 2026, 4:03 PM ET
  • Item 5.02 (Departure or Election of Directors or Officers; Compensatory Arrangements)
  • Item 9.01 (Financial Statements and Exhibits)
  • Accession number 0000318154-26-000048
Source
SEC EDGAR
Apr 22, 2026, 4:03 PM ET
Read the original ↗

SEC filing 8-K · accession 0000318154-26-000048 · sec.gov ↗